	Mole or Early Melanoma? Rethinking Early Detection, Overdiagnosis, and the Benign-Malignant Paradigm. Int J Dermatol Barnhill R, Swerlick RA. PMID: 42808963 [PubMed - indexed for MEDLINE]
	Can We Diagnose Early Melanoma by Genomics? Int J Dermatol Wyant WA, Moslehi D, Lo JA. PMID: 42808956 [PubMed - indexed for MEDLINE]
	Can We Diagnose Early Melanoma With New Imaging Technologies? Int J Dermatol Deußing M, Hartmann D. PMID: 42808955 [PubMed - indexed for MEDLINE]
	Melanoma Prognostication Using AI-Guided Histopathology. Int J Dermatol Lee E, Karagenova R, Semenov YR. PMID: 42808954 [PubMed - indexed for MEDLINE]
	What Is Pediatric Melanoma? Clinical and Genomic Features and the Role of Next-Generation Sequencing in Tumor Classification. Int J Dermatol Sargen MR. PMID: 42808951 [PubMed - indexed for MEDLINE]
	Dermoscopy and the Early Melanoma Concept. Int J Dermatol Scharf C, Nicoletti MM, Argenziano G. PMID: 42808948 [PubMed - indexed for MEDLINE]
	Spatial Proteomics as a Potential Decision-Support Layer forÂ Early Melanoma: A Narrative Review. Int J Dermatol Szadai L, Gil J, Marko-Varga G. PMID: 42808946 [PubMed - indexed for MEDLINE]
	Melanoma in Skin of Color: Diagnostic Challenges, Overdiagnosis, and Emerging Tools. Int J Dermatol Breinholt J, Starghill M, Costello CM. PMID: 42808945 [PubMed - indexed for MEDLINE]
	Real-World Outcomes of Immune Checkpoint Inhibitors in Melanoma, Including Acral and Mucosal Subtypes: A Retrospective Cohort Study From a Latin American Center. J Skin Cancer Avila-Rodriguez V, Vasquez JM, Molina-Pimienta L, Bonilla-Gonzalez C, Rondon-Carvajal J, Gil-Tamayo S, Rueda C, Russi A, Bruges R. PMID: 42807799 [PubMed]
	Radiotherapy for overcoming immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma. Front Immunol Du C, Li Y. PMID: 42807764 [PubMed - indexed for MEDLINE]
	Vertebral Sarcoidosis Mimicking Metastatic Disease in a Patient With Prior Melanoma: A Diagnostic Challenge. Cureus Garcia Salazar AA, Alfonso García CB, Filiberto Arevalo JL, Fernandez Eng IL, Yakubu A. PMID: 42807674 [PubMed]
	Assessment of Factors and Trends Affecting Different Pathological Types of Cervical Cancer in China From 2013 to 2022. Cancer Med Li Y, Li R, Duan R, Gu X, You J, Wang H, Zuo T, Wang Z, Lin W, Li L, Zhu B, Zhang S, Yang W, Yuan S, Zhang H, Du L, Yin J, Yang H, Qiao Y. PMID: 42806628 [PubMed - indexed for MEDLINE]
	Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case-control study in UK NHS hospitals. BMJ Open Sharma S, Murray J, Parker A, Jamel S, Antonowicz S, Phillips A, Bailey E, Fox L, Plant C, Converso V, Ellis JK, Mukherjee S, Kumar B, Lo T, Wahed S, Alchawaf A, Moore AR, Boddy A, Scott-Brown M, Thomas B, Abdelrahman T, Pucher PH, El-Sharkawy A, Forner S, Wayman J, Elshaer A, Chan D, Mcnally S, Petty R, Patil P, Bhuva N, Periyathambi J, Bhatt L, Vohra R, Sharples L, Hanna GB, ViSON Collaborators. PMID: 42805665 [PubMed - indexed for MEDLINE]
	Vaginal melanoma: a rare and challenging diagnosis. BMJ Case Rep Simões Costa N, Santos E Pereira H. PMID: 42805624 [PubMed - in process]
	Metastatic dedifferentiated malignant melanoma with spindle cell morphology. BMJ Case Rep Olang O, Pinto CJ, Welch R, Thomas I. PMID: 42805622 [PubMed - indexed for MEDLINE]
	Cutaneous T-cell lymphoma emerging during long-term dupilumab therapy in a patient with longstanding atopic diathesis: diagnostic challenges and mechanistic considerations. BMJ Case Rep Mills S, Geist R, Daniels P, Crane J. PMID: 42805618 [PubMed - indexed for MEDLINE]
	Targeting the Untargeted: Emerging Targeted Therapies in Metastatic Melanoma Beyond BRAF/MEK Inhibitors. Crit Rev Oncol Hematol Dimitrakopoulou ME, Theocharopoulos C, Katsandri A, Foteinou D, Stefanou D, Gkoufa A, Tsoukalas K, Bousou T, Anastasopoulou A, Gogas H, Ziogas DC. PMID: 42805360 [PubMed - as supplied by publisher]
	Adjuvant anti-TIGIT plus anti-PD-1 in melanoma: A necessary failure that clarifies the path forward. Transl Oncol Ke Q, Zhou S. PMID: 42805115 [PubMed - as supplied by publisher]
	Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey. Eur J Cancer Blomen CL, Kelpe J, Kött J, Rutenkröger M, Scholl I, Schneider SW, Gebhardt C. PMID: 42804856 [PubMed - as supplied by publisher]
	Oral squamous cell carcinoma arising from oral epithelial dysplasia shows high postoperative recurrence despite favorable histopathology. Clin Oral Investig Hu Y, Zhao X, Wang M, Zhang Z, Jin S, Ma H. PMID: 42803846 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 145021

Page 1 of 7252



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy